1. Home
  2. ANIP vs IMKTA Comparison

ANIP vs IMKTA Comparison

Compare ANIP & IMKTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ANIP
  • IMKTA
  • Stock Information
  • Founded
  • ANIP 2001
  • IMKTA 1963
  • Country
  • ANIP United States
  • IMKTA United States
  • Employees
  • ANIP N/A
  • IMKTA N/A
  • Industry
  • ANIP Biotechnology: Pharmaceutical Preparations
  • IMKTA Food Chains
  • Sector
  • ANIP Health Care
  • IMKTA Consumer Staples
  • Exchange
  • ANIP Nasdaq
  • IMKTA Nasdaq
  • Market Cap
  • ANIP 1.3B
  • IMKTA 1.2B
  • IPO Year
  • ANIP N/A
  • IMKTA N/A
  • Fundamental
  • Price
  • ANIP $56.58
  • IMKTA $70.05
  • Analyst Decision
  • ANIP Buy
  • IMKTA
  • Analyst Count
  • ANIP 6
  • IMKTA 0
  • Target Price
  • ANIP $76.80
  • IMKTA N/A
  • AVG Volume (30 Days)
  • ANIP 278.1K
  • IMKTA 143.5K
  • Earning Date
  • ANIP 11-08-2024
  • IMKTA 11-27-2024
  • Dividend Yield
  • ANIP N/A
  • IMKTA 0.94%
  • EPS Growth
  • ANIP N/A
  • IMKTA N/A
  • EPS
  • ANIP N/A
  • IMKTA 8.40
  • Revenue
  • ANIP $555,456,000.00
  • IMKTA $5,827,075,484.00
  • Revenue This Year
  • ANIP $23.69
  • IMKTA N/A
  • Revenue Next Year
  • ANIP $18.95
  • IMKTA N/A
  • P/E Ratio
  • ANIP N/A
  • IMKTA $8.34
  • Revenue Growth
  • ANIP 23.60
  • IMKTA 1.17
  • 52 Week Low
  • ANIP $48.20
  • IMKTA $59.73
  • 52 Week High
  • ANIP $70.81
  • IMKTA $89.59
  • Technical
  • Relative Strength Index (RSI)
  • ANIP 42.32
  • IMKTA 57.74
  • Support Level
  • ANIP $57.80
  • IMKTA $71.01
  • Resistance Level
  • ANIP $63.23
  • IMKTA $72.93
  • Average True Range (ATR)
  • ANIP 2.43
  • IMKTA 1.92
  • MACD
  • ANIP -0.05
  • IMKTA 0.78
  • Stochastic Oscillator
  • ANIP 13.41
  • IMKTA 72.98

About ANIP ANI Pharmaceuticals Inc.

ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid dose products. Its areas of product development include narcotics, oncolytic, hormones and steroids, and complex formulations involving extended release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.

About IMKTA Ingles Markets Incorporated

Ingles Markets Inc is a U.S.-based company that is principally engaged in operating a supermarket chain. The company operates the business in the southeast United States, mainly in Georgia, North Carolina, South Carolina, and Tennessee, with a few stores in Virginia and Alabama as well. The company locates its stores majorly in suburban areas, small towns, and neighborhood areas. It offers a broad range of goods, including food products, pharmacies, health and beauty care products, and general merchandise. The retail business contributes the majority of the company's revenue. The company's real estate ownership of a material portion of total stores enables it to generate rental income.

Share on Social Networks: